Nautilus Biotechnology

E523160

Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (1)

Label Occurrences
Nautilus Biotechnology canonical 1

Statements (31)

Predicate Object
instanceOf biotechnology company
proteomics company
aimsTo accelerate drug discovery
enable comprehensive analysis of the human proteome
support biomedical research
develops high-throughput proteomics platforms
next-generation proteomics platforms
platforms for comprehensive proteome analysis
focusesOn drug discovery applications
human proteome analysis
proteomics
research applications
goal enable large-scale proteomic studies
improve sensitivity of protein detection
improve throughput of proteomics experiments
increase depth of proteome coverage
hasApplicationIn biomedical research
drug discovery
industry biotechnology
life sciences
proteomics
offers proteomics platform
serves academic research institutions
biotechnology companies
drug discovery researchers
pharmaceutical companies
subjectArea human proteome
protein biology
systems biology
technologyType high-throughput analysis
proteome-wide measurement

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Avie Tevanian boardMemberOf Nautilus Biotechnology